Beathard Robert King 3rd 13D and 13G filings for Sunshine Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-29 4:45 pm Purchase | 2021-07-20 | 13G | Sunshine Biopharma, Inc. SBFM | Beathard Robert King 3rd | 98 8.070% | 98 (New Position) | Filing |